Emily Goldberg Shares Insights as a Genetic Counselor for Breast Cancer Risk Screening

DeepSeek-R1 was able to improve diagnosis management in these subspecialties while also lowering operation costs.

A new FDA-approved blood test for Alzheimer disease could transform diagnosis and treatment accessibility, according to this conversation with Howard Fillit, MD, and Anthony “Nino” Sireci, MD, MSc.

Maintaining eye health through regulating use of technology and attending annual checkups are an important aspect of children’s health as the school year approaches.

In this conversation with Reuben Daniel, associate vice president of artificial intelligence at UPMC Health Plan, we dive into how UPMC Health Plan builds trust with providers and members, discuss challenges of scaling AI effectively, and hear about concrete examples of AI's positive impact.

A clinical trial assessing a remote weight loss intervention in women with breast cancer saw a reduction in body weight.

RIsing costs for therapies and inequities in reimbursement for genomic testing have created financial barriers for patients, according to appearing experts in Detroit, Michigan, on July 10, 2025.